Denmark· DK-28106890922
Midodrin "Zentiva"
A midodrine product containing midodrinhydrochlorid, registered in Denmark by Zentiva k.s.. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Midodrine is registered in 15 of 19 countries.
Countries holding a registration under ATC C01CA17 (midodrine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Midodrine · ATC C01CA17
15 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of midodrine costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.67 in United States to $9.42 in Switzerland — a ×14 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Midodrine · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$9.42
- FR France$2.73
- US United States$0.67 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Midodrinhydrochlorid
- Manufacturer
- Zentiva k.s.
- Country
- Denmark (DK)
- ATC code
- C01CA17
- ATC class
- Midodrine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106890922
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
115 interactions on record for midodrine.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Midodrine · interactions on record
115 records
- 2 severe
- 84 moderate
- 3 minor
- 26 info
Most severe, free to view
- Iobenguane (123I)V09IX01severe
- Iobenguane (131I)V09IX02severe
- EpinephrineA01AD01moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01CA17
Midodrine, as other registers publish it.
- CanadaAPO-MIDODRINEAPOTEX INC
- CanadaAPO-MIDODRINEAPOTEX INC
- DenmarkAugermidAspire Pharma (Malta) Limited
- DenmarkAugermidAspire Pharma (Malta) Limited
- United KingdomBramox 10mg tabletsBrancaster Pharma Ltd
- United KingdomBramox 2.5mg tabletsBrancaster Pharma Ltd
- United KingdomBramox 5mg tabletsBrancaster Pharma Ltd
- PolandGutronDelfarma Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c585df36-987f-4ddc-a1b2-6d9f2fbd8c98 GET /v1/drugs/c585df36-987f-4ddc-a1b2-6d9f2fbd8c98?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "5 mg",
"auth_role": "CMS",
"dk_drugid": "28106890922",
"substance": "Midodrinhydrochlorid",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "45618"
}See everything about midodrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.